company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3936000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3936000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2202000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2202000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1734000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4087000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2421000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6508000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4774000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,112000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-111000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.69
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.69
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1323000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q2,2013-04-01,2013-06-30,2014-09-04 17:13:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.69
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4279000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4279000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1438000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1438000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2841000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4700000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2077000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6777000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3936000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,164000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-163000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4099000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4099000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4099000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4099000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1700000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.39
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1700000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.39
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1718000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:04:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.39
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7497000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7497000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2360000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2360000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5137000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6658000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2577000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9235000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4098000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,312000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-311000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4409000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4409000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4409000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4409000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1800000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.49
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1800000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.49
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1773000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.49
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8565000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8565000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2320000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2320000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6245000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8291000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2377000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10668000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4423000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,41000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4382000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4382000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4382000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4382000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1900000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.36
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1900000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.36
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1860000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:07:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.36
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9100000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9100000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2576000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2576000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6524000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9667000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2758000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12425000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5901000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5885000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18217000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:04:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13425000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13425000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2967000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2967000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10458000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11495000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2619000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14114000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3656000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-350000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-96000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,254000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3402000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-284000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3686000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3686000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3686000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.56
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.56
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11384000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.56
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13372000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13372000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2792000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2792000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10580000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12620000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3326000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15946000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5366000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-28000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5338000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5338000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5338000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5338000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23488000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:19:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15198000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15198000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2904000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2904000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12294000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14117000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4038000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18155000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5861000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-48000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,48000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5813000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5813000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5813000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5813000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25015000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:07:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14232000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14232000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2877000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2877000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11355000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16420000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4799000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21219000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9864000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-126000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,126000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9738000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9738000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9738000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9738000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27800000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27800000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27979000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:28:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18791000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18791000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3715000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3715000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15076000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16480000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4445000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20925000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5849000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,202000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-202000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6051000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,306000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5745000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5745000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5745000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26100000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26100000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26159000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16692000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16692000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3210000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3210000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13482000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17393000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4495000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21888000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8406000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8406000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,185000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8221000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8221000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8221000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28207000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 16:04:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19317000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19317000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3117000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3117000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17795000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4588000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22383000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6183000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6183000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,224000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5959000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5959000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5959000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28379000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q2,2016-04-01,2016-06-30,2017-08-04 16:14:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18468000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18468000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2788000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2788000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15680000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17905000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4237000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22142000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6462000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6462000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,236000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6226000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6226000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6226000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28479000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:14:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24231000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24231000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3888000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3888000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20343000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19833000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5570000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25403000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5060000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5060000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,244000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4816000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4816000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4816000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28420000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20474000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20474000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2884000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2884000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17590000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20319000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4220000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24539000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6949000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6949000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,268000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6681000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6681000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6681000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29000000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29000000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28708000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23985000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23985000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3684000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3684000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20301000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18682000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4176000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22858000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2557000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2557000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,288000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2269000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2269000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2269000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28950000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 16:07:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22313000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22313000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3808000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3808000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18505000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18746000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4346000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23092000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4587000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4587000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,326000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4261000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4261000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4261000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29269000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:07:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29529000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29529000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5123000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5123000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24406000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22298000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5618000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27916000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3510000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3510000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,358000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3152000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3152000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3152000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29119000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24723000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24723000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5482000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5482000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19241000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21516000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4273000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25789000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6548000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6548000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,412000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6136000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6136000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6136000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29878000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:08:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5558000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5558000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20742000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21005000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4374000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25379000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4637000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4637000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,477000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4160000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4160000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4160000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29700000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29700000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30264000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:43:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24666000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24666000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5202000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5202000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19464000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22760000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4872000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27632000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8168000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8168000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,572000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7596000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7596000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7596000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30475000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32783000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32783000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6371000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6371000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26412000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26322000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5743000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32065000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5653000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5653000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,623000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5030000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5030000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5030000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30200000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30313000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26673000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26673000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4645000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4645000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22028000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27207000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6266000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33473000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11445000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11445000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,640000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10805000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10805000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10805000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30900000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30900000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30918000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 09:28:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26659000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26659000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5046000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5046000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21613000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27611000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6041000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33652000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12039000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12039000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,655000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11384000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11384000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11384000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31600000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31600000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31362000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:43:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24056000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24056000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4876000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4876000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19180000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26429000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6145000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32574000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13394000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13394000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,546000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12848000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12848000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12848000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31300000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31483000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31754000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31754000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7206000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7206000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24548000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27233000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5831000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33064000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8516000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8516000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,559000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7957000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7957000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7957000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31400000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31388000.0
Intersect ENT Inc,XENT,549300SWZUVLSFMOXR50,0001271214,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
